PDS Biotechnology | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 18 16:18 ET
PDS Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 28 17:32 ET
PDS Biotechnology | 10-K: Annual report
Mar 28 17:22 ET
PDS Biotechnology | 8-K: Current report
Mar 27 07:34 ET
PDS Biotechnology | 8-K: Current report
Mar 13 06:08 ET
PDS Biotechnology | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.0%)
Jan 29 17:30 ET
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Shepard Kirk V.
Jan 23 00:00 ET
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Officer Shepard Kirk V.
Jan 23 00:00 ET
PDS Biotechnology | 8-K: Current report
Jan 22 00:00 ET
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Boesgaard Lars
Dec 4, 2023 18:14 ET
PDS Biotechnology | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Boesgaard Lars
Dec 4, 2023 18:11 ET
PDS Biotechnology | 8-K: Current report
Dec 4, 2023 16:02 ET
PDS Biotechnology | 8-K: Current report
Nov 28, 2023 06:02 ET
PDS Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nov 14, 2023 16:11 ET
PDS Biotechnology: Q3 2023 Earnings Report
Nov 14, 2023 16:06 ET
PDS Biotechnology | 8-K: PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 14, 2023 07:45 ET
PDS Biotechnology | 8-K: Current report
Nov 9, 2023 16:07 ET
PDS Biotechnology | 8-K: Current report
Oct 23, 2023 16:06 ET
PDS Biotechnology | 8-K: Current report
Oct 11, 2023 16:02 ET
PDS Biotechnology | 8-K: Current report
Oct 3, 2023 16:03 ET
No Data
No Data